How does intensive medical therapy (IMT) compare with surgical treatment in improving patients' quality of life?
Read More »Combination Therapy with Metformin and an SGLT2 Inhibitor
Black patients may have lower odds of achieving target HbA1C levels on metformin and SGLT2 alone.
Read More »Low-Fat Plant-Based Diet Is Effective for Reducing Body Weight and Increasing Insulin Sensitivity
A 16-week low-fat plant-based diet significantly improves diabetes parameters in adult patients with type 2 diabetes mellitus (T2DM).
Read More »More Physical Activity May Be Needed to Lower Gestational Diabetes Risk
Is the current guidelines’ recommendation of moderate exercise for 150 minutes per week during pregnancy enough to reduce the risk of gestational diabetes?
Read More »Insight Into Turmeric Benefits in Diabetes and CVD
Examining how curcumin and other bioactive compounds in turmeric lower blood glucose.
Read More »Starting the New Year and Getting Rid of Type 2 Diabetes?
By Sheri Colberg, PhD
I recently was asked about the latest research on the reversal of type 2 diabetes—both bariatric and non-bariatric solutions—and it made me wonder about the mechanisms of this possibility and what role being active may play in it. Each new year always brings a whole host of resolutions that people make focused on losing weight, getting more fit, and becoming healthier. Especially with all the COVID-related pounds I have heard about people gaining, I expect these resolutions to be out in full force at the start of 2022. But how effective will they be long-term, and is the reversal of type 2 diabetes a realistic resolution to make?
Cost-effectiveness of SGLT2 Inhibitors in Patients with Heart Failure with Reduced Ejection Fraction
Sodium-glucose cotransporter 2 (SGLT2) inhibitors were created to treat diabetes, but noted to ameliorate cardiovascular events.
Read More »High Deductibles Leading to Reduced Medication Adherence Among Patients with Diabetes
Health plans with high deductibles require thousands of dollars out-of-pocket and have a known association with delays in treatment; a repeated cross-sectional study found they are also associated with medication non-adherence.
Read More »SGLT2is and GLP-1 RAs Show Best Cardiovascular Results when Initiated Sooner
The case for why an SGLT2 inhibitor or GLP-1 receptor agonist should be initiated early in diabetes treatment, regardless of whether the patient is on insulin therapy.
Read More »Gut Microbiome – Identifying Children with Type 1 Diabetes
Artificial intelligence fingerprints gut flora, linking clusters of microbial species with type 1 diabetes development.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.